Advertisement
Person › Details
Naveed Siddiqi (Novo Ventures)
Siddiqi, Naveed (Novo Ventures 201912– Partner before 201312– Partner at EdRIP BioDiscovery Funds + Phase4 Ventures)
Organisation | Novo Ventures | |
Group | Novo Group (Group) | |
Former/major organisation | Edmond de Rothschild Investment Partners (EdRIP) | |
Today | Andera Partners (FR) | |
Group | Andera Partners (FR) | |
Product | venture capital | |
Product 2 | LIFE SCIENCES | |
Record changed: 2024-07-17 |
Advertisement
More documents for Naveed Siddiqi
- [1] Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA....
- [2] Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel....
- [3] Novo Holdings A/S. (8/12/20). "Press Release: Novo Ventures Portfolio Company F2G Closes US$60.8 Million Financing". Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top